[HTML][HTML] Long noncoding RNAs as promising biomarkers in cancer

O Beylerli, I Gareev, A Sufianov, T Ilyasova… - Non-coding RNA …, 2022 - Elsevier
Despite many advances in diagnosis and therapy (surgery, radiation therapy,
chemotherapy), cancer remains one of the most important public health problems …

Prostate cancer liquid biopsy biomarkers' clinical utility in diagnosis and prognosis

M Matuszczak, JA Schalken, M Salagierski - Cancers, 2021 - mdpi.com
Simple Summary In prostate cancer, overdiagnosis and overtreatment is a common problem
for clinicians. Accurate diagnosis and prognosis are essential to avoid unnecessary biopsy …

Association between combined TMPRSS2: ERG and PCA3 RNA urinary testing and detection of aggressive prostate cancer

MG Sanda, Z Feng, DH Howard, SA Tomlins… - JAMA …, 2017 - jamanetwork.com
Importance Potential survival benefits from treating aggressive (Gleason score,≥ 7) early-
stage prostate cancer are undermined by harms from unnecessary prostate biopsy and …

Beyond PSA: the role of prostate health index (phi)

M Ferro, O De Cobelli, G Lucarelli, A Porreca… - International Journal of …, 2020 - mdpi.com
Background: Widespread use of prostate specific antigen (PSA) in screening procedures
allowed early identification of an increasing number of prostate cancers (PCas), mainly …

LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27Kip1

G Luo, D Liu, C Huang, M Wang, X Xiao, F Zeng… - Molecular Cancer …, 2017 - AACR
Recent studies have demonstrated that long noncoding RNAs (lncRNA) have important
roles in cancer biology, and that the downregulation of lncRNA growth arrest–specific …

A multi-institutional prospective trial confirms noninvasive blood test maintains predictive value in African American men

S Punnen, SJ Freedland, TJ Polascik, S Loeb… - The Journal of …, 2018 - auajournals.org
Purpose: The 4Kscore® test accurately detects aggressive prostate cancer and reduces
unnecessary biopsies. However, its performance in African American men has been …

RGS12 is a novel tumor-suppressor gene in African American prostate cancer that represses AKT and MNX1 expression

Y Wang, J Wang, L Zhang, OF Karatas, L Shao… - Cancer research, 2017 - AACR
African American (AA) men exhibit a relatively high incidence and mortality due to prostate
cancer even after adjustment for socioeconomic factors, but the biological basis for this …

Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: Racial, ethnic, and geographical considerations

R Morgan, WA da Silveira, RC Kelly… - Expert review of …, 2021 - Taylor & Francis
Introduction Advances in high-throughput sequencing have greatly advanced our
understanding of long non-coding RNAs (lncRNAs) in a relatively short period of time. This …

Liquid biomarkers for early detection of prostate cancer and summary of available data for their use in African-American men

GM Henning, GL Andriole, EH Kim - Prostate Cancer and Prostatic …, 2022 - nature.com
Background Several liquid biomarker tests have been developed to account for the
limitations of prostate specific antigen (PSA) screening prior to prostate biopsy. African …

Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017

SV Carlsson, MJ Roobol - Current opinion in urology, 2017 - journals.lww.com
There are numerous tests available that can help increase the specificity of PSA, in the initial
and repeat biopsy setting. All coincide with a small decrease in sensitivity of detecting high …